GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Copland Road Capital Corp (XCNQ:CRCC) » Definitions » Revenue per Share

Copland Road Capital (XCNQ:CRCC) Revenue per Share : C$0.00 (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Copland Road Capital Revenue per Share?

Copland Road Capital's revenue per share for the three months ended in Mar. 2024 was C$0.00. Copland Road Capital's revenue per share for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Copland Road Capital's Revenue per Share or its related term are showing as below:

During the past 13 years, Copland Road Capital's highest 3-Year average Revenue Per Share Growth Rate was 126.80% per year. The lowest was -90.60% per year. And the median was -47.70% per year.

XCNQ:CRCC's 3-Year Revenue Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.4
* Ranked among companies with meaningful 3-Year Revenue Growth Rate only.

Copland Road Capital Revenue per Share Historical Data

The historical data trend for Copland Road Capital's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Copland Road Capital Revenue per Share Chart

Copland Road Capital Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Dec20 Dec21 Dec22 Dec23
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 - - - -

Copland Road Capital Quarterly Data
Apr19 Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Copland Road Capital's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Copland Road Capital's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Copland Road Capital's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Copland Road Capital's PS Ratio distribution charts can be found below:

* The bar in red indicates where Copland Road Capital's PS Ratio falls into.



Copland Road Capital Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Copland Road Capital's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=0/10.821
=0.00

Copland Road Capital's Revenue Per Share for the quarter that ended in Mar. 2024 is calculated as

Revenue Per Share (Q: Mar. 2024 )=Revenue (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=0/11.069
=0.00

Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Copland Road Capital  (XCNQ:CRCC) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Copland Road Capital Revenue per Share Related Terms

Thank you for viewing the detailed overview of Copland Road Capital's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Copland Road Capital (XCNQ:CRCC) Business Description

Traded in Other Exchanges
N/A
Address
217 Queen Street West, Suite 401, Toronto, ON, CAN, M5V 0R2
Copland Road Capital Corp is an investment company. It focuses on making investments in the cannabis industry. It generates revenue from Retail and wholesale, which includes the sale of physical cannabis goods. The company discontinued all its operations.
Executives
Scott Kelly 10% Security Holder, Director

Copland Road Capital (XCNQ:CRCC) Headlines

No Headlines